Ruiying optimal blood glucose monitoring system
Taiwan·Risk Class 2·SunYao Technology Co., Ltd. Shulin Plant;; Ruiying Biopharmaceutical Technology Co., Ltd·Registered Dec 18, 2020 – Dec 18, 2025Expired- Analysis ID
- 663b42963b0012700f3a264e33a568fa
- Manufacturer
- SunYao Technology Co., Ltd. Shulin Plant;; Ruiying Biopharmaceutical Technology Co., Ltd
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- AURUM BIOMEDICAL TECHNOLOGY, INC.
- Intended Use
- This product is used to quantify the blood glucose value of fresh microvascular whole blood and can be used by patients for self-testing. It is for in vitro diagnostic use only and should not be used as a diabetes diagnostic tool, and this product is not suitable for newborn testing. This product is intended for single use only.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical); A.1345 Glucose test system
- Import Information
- 國產;; QMS/QSD
- Registration Date
- Dec 18, 2020
- Expiry Date
- Dec 18, 2025
Access comprehensive regulatory information for Ruiying optimal blood glucose monitoring system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 663b42963b0012700f3a264e33a568fa and manufactured by SunYao Technology Co., Ltd. Shulin Plant;; Ruiying Biopharmaceutical Technology Co., Ltd. The authorized representative in Taiwan is AURUM BIOMEDICAL TECHNOLOGY, INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.